Quantity size:
0.2ml
Concentration:
1mg/ml 糖原蛋白1 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Glycogen synthesis is initiated by the autoglucosylation of Glycogenin-1. Specifically, Glycogenin-1 glucosylates itself to begin the synthesis of glycogen in mammalian skeletal muscle. It acts as the primer to which further glucose monomers may be added. All of the 糖原蛋白1Glycogenin-1 molecules contain at least one glucosyl residue before autoglucosylation begins. The first step of the glycogen synthesis occurs when a glucose molecule from UDP-glucose binds to the hydroxyl group of Tyr 194 on the Glycogenin-1 molecule. Using its glucosyltransferase activity, Glycogenin-1 adds more glucoses, each one coming from UDP-glucose. The glycosylation process reaches a plateau when five new glucose residues have been added, at糖原蛋白1 which point glycogen synthase (GS) takes over and further elongates the chain. Glycogenin-1 remains covalently attached to the reducing end of the glycogen molecule.
糖原蛋白1Also known as:
Glycogenin; Glycogenin-1; Glycogenin1; GLYG_HUMAN; GN-1; GN1; GYG 1; GYG; GYG1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Glycogen.
●
Predicted Molecular Weight: 39kDa.
糖原蛋白1Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl889Ca01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)
kl889Hu01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)
kl889Mu01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)
kl889Ra01肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)
kl889Rb51肾素(REN)多克隆抗体Polyclonal Antibody to Renin (REN)
kl890Ca01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Mu01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Po01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Ra01表面活性物质关联蛋白A(SPA)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl891Hu01花生四烯酸-15-脂加氧酶(ALOX15)多克隆抗体Polyclonal Antibody to Arachidonate-15-Lipoxygenase (ALOX15)
kl895Hu01胰岛素受体(ISR)多克隆抗体Polyclonal Antibody to Insulin Receptor (ISR)
kl895Ra01胰岛素受体(ISR)多克隆抗体Polyclonal Antibody to Insulin Receptor (ISR)
kl896Po01半胱氨酸蛋白酶抑制剂3(CST3)多克隆抗体Polyclonal Antibody to Cystatin 3 (CST3)
kl897Hu01血红蛋白μ(HBμ)多克隆抗体Polyclonal Antibody to Hemoglobin Mu (HBm)
kl899Ca01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)
kl899Mu01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)
kl899Po01骨桥素(OPN)多克隆抗体Polyclonal Antibody to Osteopontin (OPN)
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话